-
মানুষজন সবকটি দেখুন
যাচাইকৃত অ্যাকাউন্ট@LLSusa Since 1949, we’ve pioneered groundbreaking research.
#Cancer is tough but we are born to defeat it. For#patient support visit: http://bit.ly/IRCLLSযাচাইকৃত অ্যাকাউন্ট@LouisJDeGennaro Louis J. DeGennaro, Ph.D., is
#president and#CEO of@LLSusa. DeGennaro has served as LLS chief mission officer since 2009. -
My Princess. She was so brave yesterday having her chemotherapy.. she seems to be taking it well..
#lymphoma#chemotherapy#mychemobuddy#Labrador#dogsoftwitterpic.twitter.com/YXwOLZDCR3
-
#California judge rules hundreds of lawsuits against@MonsantoCo and@Bayer over link between#Roundup weed killer and#cancer can move forward https://www.hop-law.com/roundup-cancer-lawsuits-against-monsanto-and-bayer-can-go-to-trial-california-judge-rules/ …#lymphoma#glyphosatepic.twitter.com/jBLZPFWhcs
-
Allogeneic hematopoietic stem cell transplantation for T-cell
#lymphoma#bmtsm#lymsmhttp://www.bloodjournal.org/content/132/3/245 … -
We're holding a brand new conference focusing specifically on
#clinicaltrials for#lymphoma! If you want to learn about clinical trials then why not join us in your local area this September? Find out more here: http://bit.ly/2JgP4ZE#TrialsLink#TrialsLinkLive#LymphomaMatterspic.twitter.com/H9O83B3FQ4
-
The authors of "Pathogenesis of follicular lymphoma" argue there is increasing evidence that follicular
#lymphoma#tumour cells re-educate the tumour microenvironment to their advantage. Read more https://bit.ly/2mqy2iG -
Case report - Toxic epidermal necrolysis (TEN)
#toxicepidermalnecrolysis associated with the use of#nivolumab (PD-1 inhibitor) for#lymphoma https://buff.ly/2NnZgle Open Access#christieresearchers@TheChristieNHS@TheChristieSoO@OncologyMedical@JAADjournals pic.twitter.com/1AJLEDK7Uu
-
MC: A third ongoing
@isth SSC Haemostasis and Malignancy project is looking at the treatment and prevention of venous thromboembolism (#VTE) in patients with#lymphoma.#ISTHSSC18#cancer#thrombosis -
Practice changing research from
@PeterMacCC from Prof John Seymour and Prof Michael MacManus showing the benefit of adding systemic therapy to IFRT in Follicular#Lymphoma#radonc http://ascopubs.org/doi/abs/10.1200/JCO.2018.77.9892 …@ASTRO_org -
Me & my team
@LymphomaAction are coming to#Glasgow to host a#Lymphoma conference - please spread the word@farrell_katrina@shelbyeilidh@KEC83@AdamsCalum@MacmillanGL@maggiesglasgow@Beatson_Charity@ScottishGenomes@CRUKGlasgow See you@studiovenues Hope Street 8 Septhttps://twitter.com/mee_helen/status/1019569279111397376 …
-
Up-front rituximab maintenance improves outcome in patients with follicular
#lymphoma: a collaborative Nordic study http://www.bloodadvances.org/content/2/13/1562?sso-checked=true …pic.twitter.com/8JGbtBOiWc
-
Call-out to my Scottish contacts: if you have been personally affected by
#lymphoma & want to learn more about the latest research into treatments & clinical trials - join us 8 Sept in#Glasgow for@LymphomaAction#LymphomaTrialsLinkLive event https://lymphoma-action.org.uk/events/lymphoma-trialslink-live-glasgow …pic.twitter.com/OcydDdltFO
-
On the reading list - review of how
#lymphoma evades immune system: hide (downregulate key immune mediating molecules) or defend (resist apoptosis or express proteins which inhibit immune system).#lymsm http://www.haematologica.org/content/early/2018/07/12/haematol.2017.184192.long …pic.twitter.com/Hxn1C8E1if
-
Final nail in coffin for bone marrow Bx in
#Hodgkin#lymphoma? Negative predictive value 99% and positive predictive value 95% (picked up 19/20 BM+ patients) when BM reference. In addition picked up 110 pts with bony PET lesions negative by Bx. 832 pt study by GHSG.#lymsmpic.twitter.com/XW51rRh8it
-
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell
#lymphoma http://www.bloodjournal.org/content/132/2/179?sso-checked=true …pic.twitter.com/aEKYRlaFk3
-
At the Panpacific Lymphoma conf. Looking forward to a great meeting with the best view!
#Lymphoma#Mauipic.twitter.com/CIkKKx0Hz8
-
See patient’s perspective of CAR T-cell therapy for Diffuse Large B-Cell Lymphoma. http://bit.ly/2KXmOkl . Glad to have been part of Zuma-1 trial that lead to FDA approval of Axi-Cel.
@ClevelandClinic#CleClinicCancer,#lymphoma,#tcellrx -
Dr. David Hodgson and the International
#Lymphoma#Radiation Oncology Group publish guidelines on the role of#radiationtherapy in patients with relapsed or refractory Hodgkin Lymphoma. Read it here: http://bit.ly/2NFCJkP#RMPatPM#hodgkinslymphomapic.twitter.com/iNFaKwmb5J
-
#ServeLifeAfterDeath#MyMomMyRoleModel Our#Mother was the first volunteer in our family to donate her body for research after bravely fighting#cancer (Non Hodgkins#lymphoma) for 14 years. She was a real inspiration, a lady of strong will power
pic.twitter.com/fTe6BBN1aY
-
The crack
#Hodgkin#lymphoma discussion team!@DrAnasYounes@DrDavidStraus and Rob Chen. Interesting session - highlighted difference between US and European practise. Younes - not referred a patient for BMT in 10y! I have referred several this year. Food for thought.@GoToPERpic.twitter.com/N6E2ai03CU
-
Concise summary of current optimal approaches to relapsed & refractory classic Hodgkin
#lymphoma today integrates strategies that include novel targeted therapies & immunotherapy. https://ja.ma/2KSw2OR pic.twitter.com/Wx0gAknNSR
লোড হতে বেশ কিছুক্ষণ সময় নিচ্ছে।
টুইটার তার ক্ষমতার বাইরে চলে গেছে বা কোনো সাময়িক সমস্যার সম্মুখীন হয়েছে আবার চেষ্টা করুন বা আরও তথ্যের জন্য টুইটারের স্থিতি দেখুন।